Format

Send to

Choose Destination
Nat Methods. 2018 Sep;15(9):748. doi: 10.1038/s41592-018-0118-8.

Author Correction: Genetically engineered cerebral organoids model brain tumor formation.

Author information

1
Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.
2
MC Toxicology Consulting, Vienna, Austria.
3
Bio-X Institute, Shanghai Jiao Tong University, Shanghai, China.
4
Vienna Biocenter Core Facilities (VBCF), Vienna, Austria.
5
Research Institute of Molecular Pathology (IMP), Vienna, Austria.
6
Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria. juergen.knoblich@imba.oeaw.ac.at.

Abstract

In the originally published paper, the "before" image for the afatinib condition in Fig. 6c was incorrect. Instead of an image displaying a GBM-3 neoplastic organoid before afatinib treatment, this panel showed an image from the GBM-2 control (DMSO) group before treatment. This error has now been corrected in the HTML and PDF versions of the article; the "before, afatinib" panel in Fig. 6c now shows a representative image from the indicated experiment. The color of all error bars in Fig. 6 has also been changed to black, for consistency. All statistical analysis and all conclusions presented in the article are unaffected by this error. Nevertheless, we apologize for the mistake.

PMID:
30135560
DOI:
10.1038/s41592-018-0118-8

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center